Machine Learning Applications in Drug Discovery and Development
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2023, Vol 7, Issue 4
Abstract
Machine learning has emerged as a powerful tool in the field of drug discovery and development, revolutionizing the way pharmaceutical research is conducted. This abstract provides a concise overview of the key applications and impacts of machine learning in this domain. Drug discovery and development is a complex, time-consuming, and costly process that traditionally relies on trial-and-error experimentation. Machine learning, with its ability to analyze vast datasets and extract meaningful insights, has significantly accelerated and optimized various aspects of this process. One crucial application of machine learning in drug discovery is the prediction of potential drug candidates. Machine learning models can also aid in the identification of biomarkers for diseases, enabling more targeted drug development. In the clinical trial phase, machine learning algorithms assist in patient selection, monitoring, and optimization of trial protocols. Predictive models can identify patient subpopulations most likely to respond to a particular treatment, leading to more efficient trials and better patient outcomes. Additionally, machine learning has streamlined drug repurposing efforts by identifying existing drugs with potential new applications. This approach has the potential to save significant time and resources by leveraging existing safety and efficacy data. Furthermore, machine learning enhances the drug development pipeline by optimizing drug formulation and dosage, predicting adverse reactions, and assisting in regulatory compliance. While machine learning offers tremendous promise in drug discovery and development, it also presents challenges related to data quality, model interpretability, and regulatory approval. Addressing these challenges will be crucial for maximizing the potential of machine learning in the pharmaceutical industry.
Authors and Affiliations
Sreelekha M, Lakshmi Bhavani P, Sudheer G and Sushma D*
Keywords
Related Articles
- EP ID EP751861
- DOI 10.23880/oajpr-16000290
- Views 32
- Downloads 0
Analytical Method Development and Validation of Bendamustine in Bulk Using RP-HPLC
A simple, sensitive, precise, accurate and economical method was developed and validated for the estimation of Bendamustine in bulk or formulation by RP-HPLC method using Inertsil column ODS of dimensions ODS -2, (150 x...
Quality Control of Certain Herbal Preparations Used for Respiratory Disorders in The Egyptian Market
Background: Herbal medicines comprise a crucial traditional remedy in the treatment of various respiratory ailments. However, the quality control of these herbal drugs is regarded as a main obstacle for their safety and...
Benomyl- or Carbendazim-Induced Androgen Receptor Disrupting Might Lead to Spinal and Bulbar Muscular Atrophy in Multi-Generations of Rats
We have reported that benomyl and its metabolite carbendazim induced reproductive and developmental toxicity and endocrine-disrupting activity in rats. The exactly underlying mechanism of reproductive and developmental t...
Unveiling the Therapeutic Landscape of Oseltamivir: Exploring Drug Utilization, Adverse Reactions and Interactions with Comorbidities-A Prospective Study
Objective: This study aimed to investigate adverse drug reactions (ADRs) associated with Oseltamivir in the presence of various co-morbidities. The objective was to analyze prescription patterns, administration rational...
In-silico Study for African Plants with Possible Beta-Cell Regeneration Effect through Inhibition of DYRK1A
Background: The continuous destruction of normal insulin-producing pancreatic beta cells is a contributing factor in all common forms of diabetes, due to insufficient production of insulin, especially in type 1 diabetes...